Skip to main content
  • Biolimus DCB Non-Inferior to Paclitaxel DCB in Treating DES-ISR: BIO ASCEND ISR Trial

    In the treatment of patients with coronary drug-eluting stent in-stent restenosis (DES-ISR), a novel biolimus-coated balloon (BCB) showed similar angiographic outcomes to the clinically proven paclitaxel-coated balloon (PCB), according to a new study.

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies. Review our Privacy Policy for more details